Arian Lundberg

I obtained my PhD from the Karolinska Institute, where I focused on transcriptional gene expression signatures to improve therapy selection and outcomes for breast cancer patients.

In 2019, I began a postdoctoral position at Stanford University, working on personalized cancer medicine and my research there centered on immune-responsive cancers, including Triple Negative Breast Cancer, Colorectal Cancer, and Melanoma, aiming to enhance therapeutic strategies.

In 2020, I joined the University of California, San Francisco, contributing to the StandUp2Cancer WCDT cohort, the largest collection of metastatic castration-resistant prostate cancer (mCRPC) patients in the U.S.

Then, I joined the Institute of Cancer Research and Royal Marsden Hospital in London, UK, as a senior postdoctoral position under Prof. Johann de Bono, where I focused on the translational aspects of mCRPC, leveraging large prostate cancer cohorts from the UK.

I am also a member of the Swedish Trans-Atlantic Researchers and Scholars Network (STARS), connecting with talented Swedish scientists across the globe.

In 2024, I was awarded the Data-Driven Life Science Fellowship from the Knut and Alice Wallenberg Foundation, hosted by KTH Royal Institute of Technology where I have my lab at the department of Protein Sciences, the Division of Systems Biology. In my lab, we explore the microbiome’s impact on cancer progression and its clinical implications.

Feel free to reach out to discuss collaborations or exchange ideas in the field of cancer research!